Accepted for Publication: September 4, 2019.
Published Online: January 6, 2020. doi:10.1001/jamapediatrics.2019.5204
Correction: This article was corrected on March 2, 2020, to remove a key that had been incorrectly included in Figure 1.
Corresponding Author: Sarah B. Mulkey, MD, PhD, Division of Fetal and Transitional Medicine, Children’s National Hospital, 111 Michigan Ave NW, Washington, DC 20010 (sbmulkey@childrensnational.org).
Author Contributions: Dr Mulkey had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Drs DeBiasi and Cure are co–senior/last authors.
Concept and design: Mulkey, Arroyave-Wessel, Russo, Msall, du Plessis, DeBiasi, Cure.
Acquisition, analysis, or interpretation of data: Mulkey, Peyton, Bulas, Fourzali, Jiang, Russo, McCarter, Msall, DeBiasi.
Drafting of the manuscript: Mulkey, DeBiasi.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Mulkey, Jiang, McCarter.
Obtained funding: Mulkey, DeBiasi.
Administrative, technical, or material support: Arroyave-Wessel, Bulas, Russo, Msall, DeBiasi.
Supervision: Mulkey, McCarter, du Plessis, DeBiasi, Cure.
Conflict of Interest Disclosures: Dr Mulkey reported receiving grants from the Thrasher Research Fund during the conduct of the study. Drs Mulkey and DeBiasi reported providing technical expertise to the Zika studies by the Centers for Disease Control and Prevention outside the submitted work. Dr Fourzali reported receiving other compensation from the Children’s National Hospital outside the submitted work. No other disclosures were reported.
Funding/Support: This study was funded in part by a grant from the Thrasher Research Fund (Drs Mulkey [principal investigator], du Plessis, and DeBiasi); awards UL1TR001876 and KL2TR001877 from the National Institutes of Health National Center for Advancing Translational Sciences (Dr Mulkey); and grant HRSA/MCHB T73 MC11047 from the Leadership Education in Neurodevelopmental and Related Disorders Training Program (Dr Msall).
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The views expressed herein are those of the authors and do not reflect the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.
Additional Contributions: We thank the women, infants, and their families who participated in the assessments and Children’s National Hospital for supporting the congenital Zika program. The following members of the BIOMELAB team in Barranquilla, Colombia, ensured the success of this study: Yazmin Martinez and Jose Ospino, primary research coordinators, as well as Edna Acosta, Yhina Samper, Donella Santiago, Alsira Diaz, Donella Santiago, and Ana Cecilia Perez. Gilbert Vezina, MD, Children’s National Hospital, provided interpretation of the fetal and neonatal imaging. Youssef A. Kousa, DO, PhD, Children’s National Hospital, served as a resource for his research in the congenital Zika program, and Armando Morales, MD, Sabbag Radiologos, served as a resource for his work in fetal and neonatal neuroimaging. Christopher Swisher, BS, and Caitlin Cristante, BS, Children’s National Hospital, provided research coordination. E. Morales-Monforte, PhD, Hospital Sant Joan de Deu Barcelona, provided a written Spanish-language AIMS (Alberta Infant Motor Scale) training class. These individuals received no additional compensation outside of their usual salary for their contributions.
5.van der Linden
V, Pessoa
A, Dobyns
W,
et al. Description of 13 infants born during October 2015-January 2016 with congenital Zika virus infection without microcephaly at birth - Brazil.
MMWR Morb Mortal Wkly Rep. 2016;65(47):1343-1348. doi:
10.15585/mmwr.mm6547e2PubMedGoogle ScholarCrossref 6.Aragao
MFVV, Holanda
AC, Brainer-Lima
AM,
et al. Nonmicrocephalic infants with congenital Zika syndrome suspected only after neuroimaging evaluation compared with those with microcephaly at birth and postnatally: how large is the Zika virus “iceberg”?
AJNR Am J Neuroradiol. 2017;38(7):1427-1434. doi:
10.3174/ajnr.A5216PubMedGoogle ScholarCrossref 7.Lage
M-LC, Carvalho
AL, Ventura
PA,
et al. Clinical, neuroimaging, and neurophysiological findings in children with microcephaly related to congenital Zika virus infection.
Int J Environ Res Public Health. 2019;16(3):E309. doi:
10.3390/ijerph16030309PubMedGoogle Scholar 9.Russell
K, Oliver
SE, Lewis
L,
et al. Update: interim guidance for the evaluation and management of infants with possible congenital Zika virus infection - United States, August 2016.
MMWR Morb Mortal Wkly Rep. 2016;65(33):870-878. doi:
10.15585/mmwr.mm6533e2PubMedGoogle ScholarCrossref 12.Centers for Disease Control and Prevention. WHO growth standards are recommended for use in the U.S. for infants and children 0 to 2 years of age.
https://www.cdc.gov/growthcharts/who_charts.htm. Updated September 9, 2010. Accessed April 24, 2019.
16.Piper
MC, Darrah
J. Motor Assessment of the Developing Infant. Philadelphia, PA: Saunders; 1994.
17.Park
JJ. Development of a functional assessment tool in children birth to 36 months: validation study of Warner Initial Developmental Evaluation of Adaptive and Functional Skills (Warner IDEA-FS) in typical and atypical children [master’s thesis]. Chicago, IL: University of Chicago; 2010.
19.Harris
PA, Taylor
R, Thielke
R, Payne
J, Gonzalez
N, Conde
JG. Research Electronic Data Capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support.
J Biomed Inform. 2009;42(2):377-381. doi:
10.1016/j.jbi.2008.08.010PubMedGoogle ScholarCrossref 20.Mooney
CZ, Duval
RD.
Bootstrapping: A Nonparametric Approach to Statistical Inference. Newbury Park, CA: Sage; 1993. doi:
10.4135/9781412983532 23.Shapiro-Mendoza
CK, Rice
ME, Galang
RR,
et al; Zika Pregnancy and Infant Registries Working Group. Pregnancy outcomes after maternal Zika virus infection during pregnancy - U.S. territories, January 1, 2016-April 25, 2017.
MMWR Morb Mortal Wkly Rep. 2017;66(23):615-621. doi:
10.15585/mmwr.mm6623e1PubMedGoogle ScholarCrossref 24.Einspieler
C, Utsch
F, Brasil
P,
et al; GM Zika Working Group. Association of infants exposed to prenatal Zika virus infection with their clinical, neurologic, and developmental status evaluated via the General Movement Assessment Tool.
JAMA Netw Open. 2019;2(1):e187235. doi:
10.1001/jamanetworkopen.2018.7235PubMedGoogle Scholar 26.Connery
AK, Berrios-Siervo
G, Arroyave
P,
et al. Responding to the Zika epidemic: preparation of a neurodevelopmental testing protocol to evaluate young children in rural Guatemala.
Am J Trop Med Hyg. 2019;100(2):438-444. doi:
10.4269/ajtmh.18-0713PubMedGoogle ScholarCrossref 28.Shin
HJ, Kim
MJ, Lee
HS, Namgung
R, Park
KI, Lee
MJ. Imaging patterns of sonographic lenticulostriate vasculopathy and correlation with clinical and neurodevelopmental outcome.
J Clin Ultrasound. 2015;43(6):367-374. doi:
10.1002/jcu.22196PubMedGoogle ScholarCrossref 33.Adebanjo
T, Godfred-Cato
S, Viens
L,
et al; Contributors. Update: interim guidance for the diagnosis, evaluation, and management of infants with possible congenital Zika virus infection—United States, October 2017.
MMWR Morb Mortal Wkly Rep. 2017;66(41):1089-1099. doi:
10.15585/mmwr.mm6641a1PubMedGoogle ScholarCrossref 34.Rice
ME, Galang
RR, Roth
NM,
et al. Vital signs: Zika-associated birth defects and neurodevelopmental abnormalities possibly associated with congenital Zika virus infection—U.S. territories and freely associated states, 2018.
MMWR Morb Mortal Wkly Rep. 2018;67(31):858-867. doi:
10.15585/mmwr.mm6731e1PubMedGoogle ScholarCrossref